Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The fluorenylmethoxycarbonyl group in solid phase synthesis.

Robert Sheppard1

  • 1Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK.

Journal of Peptide Science : an Official Publication of the European Peptide Society
|October 14, 2003
PubMed
Summary

The fluorenylmethoxycarbonyl (Fmoc) amino-protecting group revolutionized solid-phase peptide synthesis after its 1978 introduction. Its historical development is traced, highlighting its impact on peptide chemistry.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US.

Journal of the American College of Cardiology·2025
Same author

Solvent Sustainability in Drug Discovery: Where Are We Now, and How Can We Improve?

Journal of medicinal chemistry·2025
Same author

Drug discovery for epigenetics targets.

Drug discovery today·2021
Same author

Left Ventricular Enlargement, Cardiac Resynchronization Therapy Efficacy, and Impact of MultiPoint Pacing.

Circulation. Arrhythmia and electrophysiology·2020
Same author

Safety and Efficacy of Multipoint Pacing in Cardiac Resynchronization Therapy: The MultiPoint Pacing Trial.

JACC. Clinical electrophysiology·2018
Same author

Rationale and design of a randomized trial to assess the safety and efficacy of MultiPoint Pacing (MPP) in cardiac resynchronization therapy: The MPP Trial.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·2017

Area of Science:

  • Organic Chemistry
  • Biochemistry
  • Peptide Synthesis

Background:

  • The development of protecting groups is crucial for controlled peptide synthesis.
  • The fluorenylmethoxycarbonyl (Fmoc) group emerged as a key innovation in this field.
  • Solid-phase peptide synthesis (SPPS) relies on efficient and orthogonal protecting group strategies.

Discussion:

  • The introduction of the Fmoc group in 1978 marked a significant advancement.
  • Its acid-labile nature offered an alternative to base-labile protecting groups.
  • The widespread adoption of Fmoc in SPPS is a testament to its utility.

Key Insights:

  • The Fmoc group's orthogonal deprotection strategy simplifies complex peptide assembly.
  • Its mild removal conditions preserve sensitive peptide structures.

Related Experiment Videos

  • The historical trajectory of Fmoc highlights its enduring importance in peptide research.

    • Outlook:

    • Continued optimization of Fmoc-based SPPS protocols.
    • Exploration of novel Fmoc derivatives for specialized applications.
    • The foundational role of Fmoc in advancing peptide therapeutics and diagnostics.